Abstract:BACKGROUND AND OBJECTIVEMultiple drug resistance (MDR) to chemotherapeutic agents often leads to a failure to respond to chemotherapy. We utilized an in vitro chemosensitivity test to identify sensitive and effective chemotherapeutic drugs and further elucidated the correlation between the in vivo chemosensitivity and clinical outcomes.METHODSHere, we evaluated the in vitro chemosensitivity and MDR of 120 lung cancer patients to eight singledrug chemotherapies and of 291 lung cancer patients to seven chemotherapy regimens using an ATP-based tumor chemosensitivity assay (ATP-TCA). Additionally, the chemosensitivity profiles of lung adenocarcinoma patients (284 cases) and lung squamous cell carcinoma patients (90 cases) to these single-drug and chemotherapy regimens were compared. Furthermore, the correlations between the chemosensitivity and clinical outcomes were investigated in 16 stage III squamous cell carcinoma patients.RESULTS AND CONCLUSIONPTX (51.7%), TXT (43.3%), GEM (12.5%), PTX+DDP (62.5%), TXT+L-OHP (54.3%) and VP-16+DDP (16.2%) had the highest in vitro chemosensitivity rates. Approximately 31.7% of patients developed resistance to all eight single-drug chemotherapies, and 25.8% of patients displayed resistance to all seven chemotherapy regimens. In addition, lung squamous cell carcinoma was significantly more sensitive to GEM and MTA+DDP than lung adenocarcinoma (P<0.05). Further analysis showed that patients with higher drug sensitivity tended to have longer disease-free survival (18 months vs. 8.5 months) than patients displaying drug resistance (P<0.05). These results suggest that the implementation of in vitro drug susceptibility testing before chemotherapy can effectively prevent the occurrence of primary drug resistance and inappropriate drug treatment.

Study on susceptibility of eight common chemotherapy drug combinations in human cervical carcinoma cell in vitro

Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations

Evaluation of the in Vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer Using the ATP-TCA.

Study of chemosensitivity for human breast cancer cells cultivated in primary generation in vitro

Detection of Chemosensitivity of Cervical Carcinoma in Vitro by MTT Assay and Its Clinical Significance

Profiling Protein Markers Associated with the Sensitivity to Concurrent Chemoradiotherapy in Human Cervical Carcinoma.

Chemosensitivity in vitro of 25 anti-cancer drugs to primary cultured human breast cancer cells

Drug Susceptibility Test in Carcinoma of Gallbladder and Cholangiocarcinoma

Relationship Between the Expression of P27~(kip1) and Chemosensitivity of Cervical Carcinoma in Vitro

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Analysis of Drug Sensitivity and Its Guidance in Clinic in 61 Cases of Breast Cancer Cell

[Chemotherapy guidance of the drug sensitivity test in vitro in human laryngeal squamous cell carcinoma]

[Experimental study of sensitivity to chemotherapeutic agents for human endometrial carcinoma cell line]

Experimental Research on the Inhibition of Chemotherapeutic Drugs to the Breast Cancer Cell Line T47D with High Expression of SNCG

Clinical Study on Sensitivity of Oral and Maxillofacial Cancers with Chemotherapy

STUDY OF CHEMOTHERAPY SENSITIVITY IN TUMOR CELL LINES ASSESSED BY APOPTOSIS

Study on the Sensitivity of Primary Glioma Cell to Chemotherapeutic Agents in Vitro

Analysis on the Detected Chemotherapeutic Drug Sensitivity Results of Gastric Cancer Cells by Using MTT Method

Chemosensitivity Testing of Oral and Maxillofacial Cancer with Biopsy Specimens

Treatment of advanced non-small cell lung cancer with gemcitabine or docetaxel in combination with cisplatin:a systematic review

Intervention Effects of Nedaplatin and Cisplatin on Proliferation and Apoptosis of Human Tumour Cells in Vitro